Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐ κB Nuclear Translocation to Promote SASP in Senescent Microglia
Aging Cell · 2025-05 · 24 (5)
DOI: 10.1111/acel.14463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 03.01.2025. Verfasst von Zhiqiang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences, Tsinghua University, Beijing, People's Re…. Hauptthemen laut MEDLINE: Microglia, NF-kappa B, Transglutaminases, NF-KappaB Inhibitor alpha. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Key Research and Development Program of China.
Abstract (Originalsprache)
Microglia, as resident immune cells in the central nervous system (CNS), play a crucial role in maintaining homeostasis and phagocytosing metabolic waste in the brain. Senescent microglia exhibit decreased phagocytic capacity and increased neuroinflammation through senescence‐associated secretory phenotype (SASP). This process contributes to the development of various neurodegenerative diseases, including Alzheimer's disease (AD). In this study, we found that SASP was elevated in senescent microglia, and proteomics showed that Tgm2 was upregulated. Mechanistically, we revealed that Tgm2‐catalyzed covalent cross‐linking of IκBα at K22 and Q248 residues in the cytoplasm of microglia, resulting in the reduction of IκBα and nuclear translocation of NF‐κB to promote SASP production. Treatment of senescent microglia with Tgm2 inhibitors (Tg2‐IN1 and Cys‐D) resulted in reduced NF‐κB nuclear translocation and decreased SASP. Additionally, oral administration of Cys‐D significantly improved the aging phenotype in aged mice. To summarize, Tgm2 is a potential target for antiaging, and inhibitors of Tgm2 can serve as novel prophylactics or senomorphics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
- Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
ORCID-Profile: Zhiqiang Li, Shangcheng Yu, Kunlin Du, Haiteng Deng
Förderung
- National Natural Science Foundation of China
- the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- National Key Research and Development Program of China
Zitieren
APA
Li, Z., Wang, T., Du, S., Miao, Z., Zhao, Y., Tang, Y., Meng, X., Yu, S., Zhang, D., Jiang, H., Du, K., Wei, W., & Deng, H. (2025). Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐ κB Nuclear Translocation to Promote SASP in Senescent Microglia. Aging Cell, 24(5). https://doi.org/10.1111/acel.14463
Vancouver
Li Z, Wang T, Du S, Miao Z, Zhao Y, Tang Y, et al. Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐ κB Nuclear Translocation to Promote SASP in Senescent Microglia. Aging Cell. 2025;24(5). doi:10.1111/acel.14463
BibTeX
@article{Li2025,
author = {Li, Zhiqiang and Wang, Tianxiang and Du, Sijing and Miao, Zelong and Zhao, Yujiao and Tang, Yuxiang and Meng, Xianbin and Yu, Shangcheng and Zhang, Dongyuan and Jiang, Hao and Du, Kunlin and Wei, Wei and Deng, Haiteng},
title = {Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐ κB Nuclear Translocation to Promote SASP in Senescent Microglia},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {5},
doi = {10.1111/acel.14463}
}
EUVIMED